Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell ...

and medical director of the pancreatic islet cell transplant program at University of Pennsylvania Perelman School of Medicine, presented additional data from 14 adult participants in the phase 1/ ...

Australian researchers are poised to become the first in the world to take pancreatic islet cells from genetically modified ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine ...

Eledon Pharmaceuticals has revealed that two patients with type 1 diabetes achieved a 'functional cure' after receiving a transplant of insulin-producing islet cells in combination with its ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

Tonix Pharmaceuticals (TNXP) announced a collaborative research agreement under which Tonix and Makana will study Tonix’s anti-CD40L monoclonal ...

DSMB supports advancement for Sernova’s clinical trialStudy is on track to meet key clinical trial endpointsLONDON, Ontario and BOSTON, April ...

Based on their preclinical studies exploring ideal transplantation locations ... Deng cited the experience of the first patient in their self-iPSC-derived β cell islet study. Before her treatment, she ...